Intracerebral hemorrhage is a major complicating factor of thrombolytic therapy of stroke. To investigate the incidence of bleeding in animals with a diseased vascular system, thrombolysis was carried out in spontaneously hypertensive rats (SHR) after clot embolism of the right middle cerebral artery (MCA). Three hours after embolism SHR were treated with either recombinant tissue-plasminogen activator (rt-PA) or saline, and neurological deficits and intracerebral hemorrhages were evaluated after 3 days survival. Rt-PA-treated SHR exhibited a significantly higher incidence of hemorrhages than untreated rats but neurological deficits and survival rates showed a non-significant trend for improvement. This model offers the possibility of investigating the pathophysiology of post-thrombolytic complications in a clinically relevant small animal model.
[1]
T. H. Globus.
MASSIVE CEREBRAL HEMORRHAGE
,
1940
.
[2]
K. Hossmann,et al.
Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat
,
1997,
Brain Research.
[3]
A. Furlan,et al.
When is thrombolysis justified in patients with acute ischemic stroke? A bioethical perspective.
,
1997,
Stroke.
[4]
C. Warlow,et al.
Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke
,
1997,
The Lancet.
[5]
J. A. Epstein,et al.
MASSIVE CEREBRAL HEMORRHAGE: SPONTANEOUS AND EXPERIMENTALLY INDUCED
,
1953,
Journal of neuropathology and experimental neurology.